Actos News
Daiichi upbeat on drug to prevent strokes and clots - Reuters
It also said it would aim to seek approval for a diabetes drug candidate in 2011, hoping to prove its superiority to market leader Actos, but it offered ...
Daiichi upbeat on drug to prevent strokes and clots - Reuters
It also said it would aim to seek approval for a diabetes drug candidate in 2011, hoping to prove its superiority to market leader Actos, but it offered ...
NanoInk Appoints Dean Hart EVP Commercial Operations - Nanowerk LLC
At Takeda, he was instrumental in the success of Takeda’s flagship diabetes product and market leader, ACTOS®, and led the growth of Takeda’s sales force to ...
FDA starts inspecting stalled Watson facility - OutSourcing-Pharma.com
Also on hold is an approval application for Watson's branded antidiabetic, Actos (pioglitazone hydrochloride) plus MET (metformin) XR. ...
Current and Breaking News for Professionals, Consumers and Media - HealthNewsDigest.com
I am assuming that they used high doses of insulin and sulfonylureas because it's very hard to offset carbohydrate with metformin, Actos or Avandia; ...
Takeda Gains Most in Five Years on Nikko `Buy' Rating (Update2) - Bloomberg
The Osaka-based company needs a successor for its Actos, the world's best-selling diabetes medicine, to buffer sales declines expected after the patent ...
Takeda to Buy Amgen Japan Unit for Up to $902 Million (Update1) - Bloomberg
Amgen KK widens the pipeline of drugs Takeda is developing to buffer a drop in sales once Actos, its best- selling diabetes pill, faces competition from ...
GlaxoSmithKline profit down 10 percent - Philadelphia Inquirer
A competitor's drug, Actos, has gained somewhat from Avandia's fall, suggesting to Viehbacher that physicians have not lost confidence in the class. ...
Amgen Sells Drug Rights and Unit in Japan - New York Times Blogs
For Takeda, known most for its diabetes drug Actos, the deal moves it further into biologics — protein-based drugs made in living organisms. ...
The Community Pharmacy provides affordable meds - The Free Lance-Star
Examples of medications available are Actos, which retails for about $212 per month, and Nexium, at about $180 per month. Both are available as a 30-day ...
Actos RSS Feed